| RS1766025064 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1766040137 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766043404 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1766047961 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766053215 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766061264 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
APC-related disorder, Familial adenomatous polyposis 1 |
| RS1766101931 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS1766105693 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Inherited polyposis and early onset colorectal cancer - germline testing |
| RS1766130383 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766169568 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766174156 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766182274 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS1766191833 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766202141 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766207854 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1766217655 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1766221897 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766265062 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Ullrich congenital muscular dystrophy 2 |
| RS1766272355 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766298401 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766311095 |
LCA5
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1766311263 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766311895 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766312361 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, Inborn genetic diseases |
| RS1766315103 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766318937 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766329158 |
MEGF10
|
Health Risk |
Pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1766347750 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766353088 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1766367247 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766367970 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1766374212 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766374293 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766378599 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766382484 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766383947 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1766397905 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766404452 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1766404539 |
COL12A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 2, Bethlem myopathy 2 |
| RS1766408020 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766410692 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766413072 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766414666 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766416713 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766419027 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1766419869 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1766427315 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766427552 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766437216 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1766462821 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766468940 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766495554 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1766523611 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1766523945 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1766524422 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766528592 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1766535009 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1766542279 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1766552940 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS1766556883 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1766578455 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766588110 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766596437 |
MARVELD2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive |
| RS1766600757 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, APC-related disorder |
| RS1766601512 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766601813 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1766647259 |
TCOF1
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1766679390 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766679809 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1766681441 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1766682665 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS1766687373 |
EYS
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1766727068 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Febrile seizures |
| RS1766745307 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766752417 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
APC-Associated Polyposis Disorders, Hereditary cancer-predisposing syndrome |
| RS1766773164 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766773391 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1766794792 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1766797963 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1766898088 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1766993480 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS1767008778 |
POLH
|
Health Risk |
Likely pathogenic |
— |
| RS1767064064 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1767079240 |
POLH
|
Health Risk |
Pathogenic |
— |
| RS1767095714 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS1767096752 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic acidemia, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS1767108423 |
LMBRD1
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS1767111402 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS1767133183 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia, Methylmalonic acidemia |
| RS1767152512 |
FANCE
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS1767163932 |
FANCE
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS1767193145 |
CYFIP2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 65 |
| RS1767224356 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS1767238331 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1767239206 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS1767239952 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1767240242 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1767240499 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1767243474 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1767253468 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |